InnoMedica Holding AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:InnoMedica Holding AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11041
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InnoMedica Holding AG (InnoMedica) discovers and develops therapeutics for the treatment of cancer. The company develops drugs using its proprietary drug delivery technology, Talidox, based on the transport and release of active pharmaceutical agents, locally, at the target area. Its pipeline portfolio includes targeted liposomal doxorubicin TLD-1/Talidox for the treatment of advanced metastatic tumors. The company’s pipeline portfolio also includes other candidates for the therapeutic areas of autoimmune diseases such as multiple sclerosis, arteriosclerosis and chronic inflammatory diseases. It operates through a office and production facility in Bern and Marly located in Switzerland, respectively. InnoMedica is headquartered in Zug, Switzerland.

InnoMedica Holding AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
InnoMedica Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InnoMedica Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
InnoMedica Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InnoMedica Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
InnoMedica Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
InnoMedica Holding AG, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
InnoMedica Raises USD10.4 Million in Offering of Shares 10
InnoMedica Raises USD7.7 Million in Offering of Shares 11
InnoMedica Raises USD4.6 Million in Offering of Shares 12
InnoMedica Raises USD1.5 Million in Offering of Shares 13
InnoMedica Raises USD0.8 Million in Rights Offering of Shares 14
InnoMedica Raises USD0.5 Million in Offering of Shares 15
Acquisition 16
InnoMedica Acquires Yamazaki-DDS 16
InnoMedica Holding AG – Key Competitors 17
InnoMedica Holding AG – Key Employees 18
InnoMedica Holding AG – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Other Significant Developments 20
Mar 22, 2018: Innomedica Holdings: Update December-2017 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
InnoMedica Holding AG, Pharmaceuticals & Healthcare, Key Facts 2
InnoMedica Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InnoMedica Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
InnoMedica Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InnoMedica Holding AG, Deals By Therapy Area, 2012 to YTD 2018 8
InnoMedica Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
InnoMedica Raises USD10.4 Million in Offering of Shares 10
InnoMedica Raises USD7.7 Million in Offering of Shares 11
InnoMedica Raises USD4.6 Million in Offering of Shares 12
InnoMedica Raises USD1.5 Million in Offering of Shares 13
InnoMedica Raises USD0.8 Million in Rights Offering of Shares 14
InnoMedica Raises USD0.5 Million in Offering of Shares 15
InnoMedica Acquires Yamazaki-DDS 16
InnoMedica Holding AG, Key Competitors 17
InnoMedica Holding AG, Key Employees 18
InnoMedica Holding AG, Other Locations 19
InnoMedica Holding AG, Subsidiaries 19

List of Figures
InnoMedica Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
InnoMedica Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
InnoMedica Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
InnoMedica Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
InnoMedica Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InnoMedica Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
InnoMedica Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InnoMedica Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[InnoMedica Holding AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CUNA Mutual Group:企業の戦略・SWOT・財務情報
    CUNA Mutual Group - Strategy, SWOT and Corporate Finance Report Summary CUNA Mutual Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • PharmaZell GmbH:企業の戦略的SWOT分析
    PharmaZell GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Toleranzia AB-製薬・医療分野:企業M&A・提携分析
    Summary Toleranzia AB (Toleranzia) is a developer of platform technology for the treatment of autoimmune diseases. The company develops and offers products and technologies including Re-Tolerogen for the treatment of autoimmune diseases. Its Re-Tolerogen platform technology is a fusion protein for t …
  • EA Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary EA Pharma Co Ltd (EA Pharma), formerly Ajinomoto Pharmaceuticals Co Ltd, a subsidiary of Eisai Co Ltd, is a clinical research organization that develops, manufactures and sells pharmaceutical products. The organization develops pharmaceutical products based on amino acid-related technologies …
  • Nikkei Inc.:企業の戦略的SWOT分析
    Nikkei Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Fate Therapeutics Inc (FATE):企業の財務・戦略的SWOT分析
    Fate Therapeutics Inc (FATE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Clariant Ltd.:企業のM&A・事業提携・投資動向
    Clariant Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Clariant Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Sangetsu Corporation (8130):企業の財務・戦略的SWOT分析
    Sangetsu Corporation (8130) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Williams-Sonoma, Inc.:企業の戦略・SWOT・財務情報
    Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report Summary Williams-Sonoma, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • QuickLogic Corporation (QUIK):企業の財務・戦略的SWOT分析
    QuickLogic Corporation (QUIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Kering SA (KER):企業の財務・戦略的SWOT分析
    Kering SA (KER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Bank of Scotland Plc:企業のM&A・事業提携・投資動向
    Bank of Scotland Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of Scotland Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Saint-Gobain Ltd:企業の戦略的SWOT分析
    Saint-Gobain Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • ABC Supply Co. Inc.:企業のM&A・事業提携・投資動向
    ABC Supply Co. Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ABC Supply Co. Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Take-Two Interactive Software, Inc.
    Take-Two Interactive Software, Inc. - Strategy, SWOT and Corporate Finance Report Summary Take-Two Interactive Software, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • EZCORP Inc (EZPW):企業の財務・戦略的SWOT分析
    EZCORP Inc (EZPW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • McLean Electric Cooperative Inc:企業の戦略的SWOT分析
    McLean Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Breckenridge Pharmaceutical Inc:企業のM&A・事業提携・投資動向
    Breckenridge Pharmaceutical Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Breckenridge Pharmaceutical Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Satrec Initiative Co., Ltd.:企業の戦略・SWOT・財務情報
    Satrec Initiative Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Satrec Initiative Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Achillion Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析
    Achillion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Achillion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆